Article
Autophagy and inflammasome molecular interplay and activation predict poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia
2024-06-18
Abstract excerpt
<title>Abstract</title> <p>Beyond its clinical diversity and severity, acute myeloid leukemia (AML) is known for its complex molecular background and for rewiring biological processes to aid disease onset and maintenance. <italic>FLT3</italic> mutations are among the most recurring molecular entities that cooperatively drive AML, and their inhibition is a critical molecularly oriented therapeutic strategy. Despit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 34713321-0fa0-5898-b765-7d4c8f463bdb
- DOI
- 10.21203/rs.3.rs-4505184/v1
